​

Xilio Therapeutics (XLO) Revenue & Revenue Breakdown

OverviewOwnershipFinancialsChart

Xilio Therapeutics Revenue Highlights

Latest Revenue (Y)

$43.77M

Latest Revenue (Q)

$12.65M

Xilio Therapeutics Revenue by Period

Xilio Therapeutics Revenue by Year

DateRevenueChange
2025-12-31$43.77M589.88%
2024-12-31$6.34M100.00%
2023-12-31-100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31--

Xilio Therapeutics generated $43.77M in revenue during NA 2025, up 589.88% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Xilio Therapeutics Revenue by Quarter

DateRevenueChange
2026-03-31$12.65M-7.58%
2025-12-31$13.69M-28.22%
2025-09-30$19.07M135.85%
2025-06-30$8.08M175.90%
2025-03-31$2.93M69.95%
2024-12-31$1.72M-23.82%
2024-09-30$2.26M-3.99%
2024-06-30$2.36M100.00%
2024-03-31-100.00%
2023-12-31-100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31--

Xilio Therapeutics generated $12.65M in revenue during Q1 2026, up -7.58% compared to the previous quarter, and up 733.64% compared to the same period a year ago.

Xilio Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
XLOXilio Therapeutics$43.77M$12.65M
LVTXLAVA Therapeutics$11.98M-
FGENFibroGen$6.44M$3.74M
OKUROnKure Therapeutics--
PDSBPDS Bio--
TVRDTvardi Therapeutics--
KZRKezar Life Sciences--
ALGSAligos Therapeutics--
SKYESkye Bioscience--
TPSTTempest Therapeutics--

XLO Revenue FAQ

What is Xilio Therapeutics’s yearly revenue?

Xilio Therapeutics's yearly revenue for 2025 was $43.77M, representing an increase of 589.88% compared to 2024. The company's yearly revenue for 2024 was $6.34M, representing an increase of 100.00% compared to 2023. XLO's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022.

What is Xilio Therapeutics’s quarterly revenue?

Xilio Therapeutics's quarterly revenue for Q1 2026 was $12.65M, a -7.58% decrease from the previous quarter (Q4 2025), and a 331.67% increase year-over-year (Q1 2025). The company's quarterly revenue for Q4 2025 was $13.69M, a -28.22% decrease from the previous quarter (Q3 2025), and a 693.85% increase year-over-year (Q4 2024). XLO's quarterly revenue for Q3 2025 was $19.07M, a 135.85% increase from the previous quarter (Q2 2025), and a 742.51% increase year-over-year (Q3 2024).

What is Xilio Therapeutics’s revenue growth rate?

Xilio Therapeutics's revenue growth rate for the last 3 years (2023-2025) was 0%, and for the last 5 years (2021-2025) was 0%.